Pau d'Arco.Shop Taheebo Tea

Active Compounds

Lapachol and Beta-Lapachone: The Main Compounds in Pau d'Arco

Published 2026-04-11· Updated 2026-09-20

Important disclaimer

This article is for educational purposes only and is not medical advice. These statements have not been evaluated by the Food and Drug Administration. Pau d'Arco is not intended to diagnose, treat, cure, or prevent any disease. We summarize published research and traditional use — this is not a recommendation to use Pau d'Arco for any specific condition. Always consult a qualified healthcare professional before starting a new supplement, especially alongside an existing medical condition or medication.

The inner bark of Pau d'Arco (Tabebuia impetiginosa) is a complex matrix of over 100 active chemicals, but two naphthoquinones — lapachol and beta-lapachone — account for most of the studied biological activity. Understanding what each one actually does mechanistically is the key to reading the rest of this site's research articles critically instead of just taking headlines at face value.

Evidence key:Traditional UseLab / In VitroAnimal StudyHuman Trial

The Chemical Profile

In the 1960s, the National Cancer Institute took interest in these compounds after animal studies showed anti-tumor effects. Rain-Tree Nutrition's compiled data puts lapachol content in high-quality bark at roughly 2–7% by weight — a meaningful range depending on sourcing, which is part of why quality matters (see our sourcing guide).

Lapachol: The Broad-Spectrum Compound

Lab / In Vitro

Lab research has categorized lapachol as having antiviral and antibacterial properties, including reported activity against Staphylococcus aureus (including MRSA strains in vitro) and Helicobacter pylori. The proposed mechanism is a redox/oxidative-stress response that disrupts cellular respiration in the target microorganism. This is in vitro evidence; it isn't a claim that drinking Pau d'Arco tea treats a Staph or H. pylori infection in a person.

Source: Journal of Ethnopharmacology (2006); Free Radical Biology and Medicine (2020)

Beta-Lapachone: Cellular Selectivity Research

Beta-lapachone has drawn more recent scientific interest for its apparent selectivity — targeting cells with high levels of an enzyme called NQO1 while leaving typical healthy cells relatively unaffected in lab models.

Lab / In Vitro

Research describes beta-lapachone inducing apoptosis in NQO1-high cells via an oxidative burst that damages the target cell's DNA. This mechanism is under active study for its relevance to cell proliferation research — it's cell-culture evidence, not a clinical outcome. See Pau d'Arco and Cancer for how this connects to actual clinical-trial-stage research.

Source: Cancer Letters (2021)

Synergistic Power: Why the Whole Bark Matters

In the 1970s, the NCI tested isolated lapachol as a treatment; at the high doses required to work in isolation, patients experienced nausea and reduced Vitamin K activity affecting blood clotting. When the whole inner bark is used (as a tea or decoction) rather than an isolated compound, those side effects are reported far less often — likely because the other 98+ compounds in the bark, including natural Vitamin K-supporting components, offset lapachol's isolated effects. This is a recurring theme across this site: the whole-plant traditional preparation and the isolated pharmaceutical-grade compound are not interchangeable, and research on one doesn't automatically apply to the other.

Antimicrobial and Antifungal Activity

Beyond cellular research, both compounds have been studied for biofilm disruption — breaking down the protective layer bacteria and fungi (including Candida) use to hide from the immune system. Reported activity spans antifungal (against Candida albicans and other yeasts), antiviral (influenza, herpes viruses, via replication-enzyme inhibition), and antibacterial mechanisms — all primarily lab-level findings. See Pau d'Arco and Candida for the antifungal-specific research.

How to Properly Extract These Compounds

Lapachol and beta-lapachone are not water-soluble enough for a quick steep — they need heat and time to release from the bark's fibers:

  1. Use 3 tablespoons of shredded (coarse cut) inner bark per 5 cups of water.
  2. Bring to a full boil in a glass or stainless steel pot with the lid on, then reduce the heat to a gentle rolling boil.
  3. Cook covered for 30 minutes.
  4. Cool briefly, then strain.

See our full brewing guide for more detail, and Taheebo Wellness Tea for pure inner bark sourced for this method.

Precautions and Responsible Use

  • Pregnancy: not recommended, given how these compounds interact with cell replication in animal studies.
  • Blood thinning: at high doses, lapachol can have a mild anticoagulant effect — consult a doctor if on blood thinners or scheduled for surgery.
  • Dosage: start slow; large amounts of a strong decoction can cause GI upset.

Where This Leaves Us

Lapachol and beta-lapachone are, by a wide margin, the most-studied compounds behind Pau d'Arco's reputation, with a real and growing lab research base. The consistent caveat across nearly all of it: this is laboratory and animal-model science explaining why the plant has the traditional reputation it does — not, on its own, clinical proof of what happens when a person drinks the tea.

References

  1. 1.Scientific Reports (2017): "β-lapachone suppresses tumour progression by inhibiting epithelial-to-mesenchymal transition in NQO1-positive breast cancers"
  2. 2.Journal of Ethnopharmacology (2006): "Antibacterial activity of Tabebuia impetiginosa Martius ex DC (Taheebo) against Helicobacter pylori" (lapachol identified as an active constituent)
  3. 3.Free Radical Biology and Medicine (2020): "The plant-derived naphthoquinone lapachol causes an oxidative stress response in Staphylococcus aureus"
  4. 4.Annals of Clinical Microbiology and Antimicrobials (2006): "Tabebuia avellanedae naphthoquinones: activity against methicillin-resistant staphylococcal strains, cytotoxic activity and in vivo dermal irritability analysis"
  5. 5.PNAS (2007): "An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by β-lapachone"
  6. 6.Toxicology and Applied Pharmacology (2014): "Mechanistic studies of cancer cell mitochondria- and NQO1-mediated redox activation of beta-lapachone, a potentially novel anticancer agent"
  7. 7.Bioorganic & Medicinal Chemistry (2009): "Synthesis and evaluation of bioactive naphthoquinones from the Brazilian medicinal plant, Tabebuia avellanedae"
  8. 8.Cancer Letters (2021): "PCNA inhibition enhances the cytotoxicity of β-lapachone in NQO1-positive cancer cells by augmentation of oxidative stress-induced DNA damage"
Carol Wade, RH (AHG)

Reviewed by

Carol Wade, RH (AHG) — Clinical Herbalist, Ojai School of Herbal Studies